- ►diabetesjournals.org CG Bell, D Meyre, C Samson, C Boyle, C Lecoeur, M … - Diabetes, 2005 - Am Diabetes Assoc Murine models have been highly effective in identifying the monogenic forms of human obesity
discovered to date. Melanin-concentrating hormone receptor 1 (MCHR1) has been shown to
be significant in the downstream orexigenic activity of the leptin-melanocortin pathway by ... Cited by 17 - Related articles - BL Direct - All 5 versions
MG Kim, M Kim, SD Lee, J Suh - Journal of Biological Inorganic Chemistry, 2006 - Springer Abstract To provide a firm basis for the new para- digm of drug discovery based on catalysts
for oxidative cleavage of N-terminal aspartate (Asp) residues of ol- igopeptides,
oligopeptide-cleaving catalysts were sear- ched by using melanin-concentrating hormone ... Cited by 7 - Related articles - BL Direct - All 3 versions
M Kim, JW Jeon, J Suh - Journal of Biological Inorganic Chemistry, 2005 - Springer Abstract To provide a firm basis for the new paradigm of drug discovery based on peptide-cleaving
catalysts, oligopeptide-cleaving catalysts were searched for by using human angiotensin I
(Ang-I) and angiotensin II (Ang-II) as the substrates. Catalyst candidates contain- ing the ... Cited by 8 - Related articles - All 3 versions
MG Kim, M Kim, H Park, S Lee, J … - BULLETIN-KOREAN …, 2007 - newjournal.kcsnet.or.kr Bull. Korean Chem. Soc. 2007, Vol. 28, No. 7 1151 ... Theoretical Analysis and Prediction of
Catalysts for Oxidative Decarboxylation of ... Min Gyum Kim, Myoung-soon Kim, Hwangseo
Park,† Sangyoub Lee, and Junghun Suh* ... Department of Chemistry, Seoul National ... Cited by 5 - Related articles - View as HTML - BL Direct - All 3 versions
PS Chae, M Kim, CS Jeung, S Du Lee, H Park, S Lee, J … - J. Am. Chem. Soc, 2005 - pubs.acs.org Previously, we reported 1 the first artificial protease selective for a target protein by designing
synthetic homogeneous catalysts that recognized myoglobin (Mb) and cleaved the polypeptide
backbone of Mb by hydrolysis using metal complexes 2-4 as the catalytic center. If the ... Cited by 23 - Related articles - All 7 versions
JW Jeon, SJ Son, CE Yoo, IS Hong, J Suh - Bioorganic & medicinal chemistry, 2003 - Elsevier A protein-cleaving catalyst highly selective for a disease-related protein can be used as a catalytic
drug. As the first protein-cleaving catalyst selective for a protein substrate, a catalyst for myoglobin
(Mb) was designed by attaching the Cu(II) or Co(III) complex of cyclen to a binding site ... Cited by 17 - Related articles - All 5 versions
B Jang, J Suh - Notes, 2008 - newjournal.kcsnet.or.kr As a new paradigm for drug design, we have proposed catalytic drugs based on target-selective
peptide-cleaving catalysts.1-9 In the conventional approaches to design drugs that regulate the
activities of disease-related proteins such as enzymes, receptors, or ion channels, ... Cited by 6 - Related articles - View as HTML - BL Direct - All 2 versions
WT Gibson, P Pissios, DJ Trombly, J Luan, J Keogh, … - Obesity research, 2004 - geno-type.com NICHOLAS J. WAREHAM, ELEFTHERIA MARATOS- FLIER, STEPHEN O'RAHILLY, AND I. SADAF
FAROOQI. Melanin-concentrating hormone receptor mutations and human obesity: functional
analysis. Obes Res. 2004;12:743–749. Melanin-concentrating hormone (MCH), a ... Cited by 31 - Related articles - View as HTML - BL Direct - All 3 versions
WC De Mello - 2004 - books.google.com Copyright й 2004 by John Wiley & Sons Ltd, The Atrium, Southern Gate, Chichester, West Sussex
PO19 8SQ, UK Telephone (+ 44) 1243 779777 E-mail (for orders and customer service
enquiries): cs-books@ wiley. co. uk Visit our Home Page on wwrw. wileyeurope. com or ... Cited by 8 - Related articles - All 4 versions
[CITATION] Peptide-or Protein-Cleaving Agents Based on Metal Complexes
